ArticleNature communications2026

PD-1 blockade plus tyrosine kinase inhibitor remodels the tumor microenvironment in advanced renal cell carcinoma.

Liangyou Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.